The estimated Net Worth of Robert S Mills is at least $121 Mille dollars as of 15 August 2023. Robert Mills owns over 40,000 units of Tff Pharmaceuticals Inc stock worth over $121,477 and over the last 5 years Robert sold TFFP stock worth over $0.
Robert has made over 5 trades of the Tff Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Robert bought 40,000 units of TFFP stock worth $10,000 on 15 August 2023.
The largest trade Robert's ever made was exercising 67,700 units of Tff Pharmaceuticals Inc stock on 19 January 2021 worth over $169,250. On average, Robert trades about 12,381 units every 126 days since 2019. As of 15 August 2023 Robert still owns at least 55,980 units of Tff Pharmaceuticals Inc stock.
You can see the complete history of Robert Mills stock trades at the bottom of the page.
Robert's mailing address filed with the SEC is 1751 RIVER RUN, SUITE 400, , FORT WORTH, TX, 76107.
Over the last 5 years, insiders at Tff Pharmaceuticals Inc have traded over $27,239,579 worth of Tff Pharmaceuticals Inc stock and bought 1,894,491 units worth $5,305,961 . The most active insiders traders include Therapeutics, Inc. Lung, Aaron G.L. Fletcher e Harlan F Weisman. On average, Tff Pharmaceuticals Inc executives and independent directors trade stock every 25 days with the average trade being worth of $174,967. The most recent stock trade was executed by Harlan F Weisman on 15 August 2023, trading 600,000 units of TFFP stock currently worth $150,000.
tff pharmaceuticals, inc. is a clinical-stage biopharma company focused on developing and commercializing drug products based on its patented thin film freezing (tff) technology. our patented thin film freezing (tff) platform makes it possible to turn more molecules into inhalable therapies. this novel technology provides high absorption and yield, uniform particle size, gentle process and endless possibilities. tff pharmaceuticals has two lead drug candidates: voriconazole inhalation powder and tac-lac inhalation powder. the company plans to add to this pipeline by collaborating with large pharmaceutical partners. the tff platform is protected by 42 patents issued or pending in the us and internationally.
Tff Pharmaceuticals Inc executives and other stock owners filed with the SEC include: